Seyed Mehdi Sajjadi

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Induced Apoptosis

Inflammatory Response

Chronic Myeloid Leukemia

Top Venues

Molecular biology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Amin Golestani, Atefeh Rahimi, Mahsa Najafzadeh, Mahtab Sayadi, Seyed Mehdi Sajjadi
"Combination treatments of imatinib with astaxanthin and crocin efficiently ameliorate antioxidant status, inflammation and cell death progression in imatinib-resistant chronic myeloid leukemia cells". Molecular biology reports 51 (1) (2024)
Amin Golestani, Atefeh Rahimi, Mahsa Najafzadeh, Mahtab Sayadi, Seyed Mehdi Sajjadi
"Combination treatments of imatinib with astaxanthin and crocin efficiently ameliorate antioxidant status, inflammation and cell death progression in imatinib-resistant chronic myeloid leukemia cells". Molecular biology reports 51 (1) (2024)
Samira Shahraki, Fatemeh Bahraini, Behzad Mesbahzadeh, Mahtab Sayadi, Seyed Mehdi Sajjadi
Glucose increases proliferation and chemoresistance in chronic myeloid leukemia via decreasing antioxidant Properties of ω-3 polyunsaturated fatty acids in the presence of Iron. Molecular biology reports (2023)
Amin Golestani, Atefeh Rahimi, Seyed Ali Moezi Bady, Nahid Azdaki, Seyed Mehdi Sajjadi
Src homology 2-B adapter protein 3 C784 T and Methylenetetrahydrofolate reductase C677 T Polymorphisms and Inflammation Markers in ST-segment Elevation Myocardial Infarction Patients. Angiology (2023)
Amirhossein Rastgar, Mahtab Sayadi, Gholamreza Anani Sarab, Seyed Mehdi Sajjadi
Astaxanthin decreases the growth-inhibitory dose of cytarabine and inflammatory response in the acute lymphoblastic leukemia cell line NALM-6. Molecular biology reports 49 (7) (2022)